Brought to you by 
Valeant sells off its iNova subsidiary for $930mm
03 Oct 2017
Executive Summary
A firm managed by Pacific Equity Partners and the Carlyle Group is paying $930mm for Valeant Pharmaceuticals International Inc.'s iNova Pharmaceuticals Pty. Ltd. subsidiary.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com